Riverview Trust Company’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Riverview Trust Company's RGEN Position: Q1 2025 in Review
Riverview Trust Company sold out of Repligen (RGEN) in Q1 2025, closing a stake of 4 shares — an estimated $576 sold.
Riverview Trust Company first reported a position in RGEN in Q1 2022 and held it in 6 quarters. The position peaked at $16.6K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Riverview Trust Company reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
- Riverview Trust Company sold 4 Repligen shares in Q1 2025, an estimated $576.
- Riverview Trust Company first reported a position in Repligen in Q1 2022 and held it in 6 quarters.
- Riverview Trust Company's Repligen position peaked at $16.6K in Q1 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.